Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

AHA, other health organizations express concerns with the application deadline of February 19, 2019 for Accountable Care Organizations applying to participate in the Medicare Shared Savings Program beginning July 1, 2019.
AHA letter to MedPAC regarding payment recommendations for 2020.
The AHA and the Federation of American Hospitals urge Congress to oppose any legislation that would repeal current law limiting self-referral to physician-owned hospitals.
A coalition of 40 health care and public health organizations, including the AHA urge the Senate to quickly pass the Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
AHA provides feedback on the Food and Drug Administration’s request for comments on the public meeting, “Identifying the Root Causes of Drug Shortages and Finding Enduring Solutions.
AHA comments on the Centers for Medicare & Medicaid Services’ advance notice of proposed rulemaking on the International Pricing Index model for Medicare Part B drugs.
The AHA and Federation of American Hospitals “strongly believe that any public policy solution to resolve surprise bills must protect patients by prohibiting balance billing and by limiting patients’ cost-sharing to an in-network amount,” the organizations Dec. 21 told members of Congress.
AHA's comments on the proposed rule from the Departments of the Treasury, Labor and Health and Human Services that would change how employers may use health reimbursement arrangements (HRAs) to help employees finance health care coverage
AHA comments on the Centers for Medicare & Medicaid Services (CMS) proposed rule that would set forth policy changes for the 2020 and 2021 Medicare Advantage (MA) plan years.
AHA comments on the guidance modifying the regulations governing waivers under Section 1332 of the Affordable Care Act.